The global preeclampsia therapeutics market is experiencing substantial growth due to rising incidence of the condition worldwide. Preeclampsia, a serious pregnancy complication characterized by high blood pressure, affects millions of women annually. This surging prevalence, coupled with sophisticated treatment options, is driving market expansion